Oral Cancer Clinical Trials

• Pioglitazone in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
  ClinicalTrials.gov Identifier: NCT00099021 - Active, not recruiting
  lip and oral cavity cancer; Oropharyngeal Cancer; Oral Leukoplakia
  
• Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004234 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; ...
  
• Celecoxib in Treating Patients With Precancerous Lesions of the Mouth
  ClinicalTrials.gov Identifier: NCT00014404 - Active, not recruiting
  lip and oral cavity cancer; prevention of oral cancer
  
• Fenretinide in Treating Patients with Neoplasia of the Mouth
  ClinicalTrials.gov Identifier: NCT00003223 - Active, not recruiting
  lip and oral cavity cancer; prevention of oral cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients with Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00006051 - Active, not recruiting
  Throat Cancer; Oral Cancer
  
• Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00006341 - Active, not recruiting
  oral complications of cancer and cancer therapy; stage III lip and oral cavity cancer; stage II lip and oral cavity cancer; Quality of Life; ...
  
• Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00024037 - Active, not recruiting
  oral complications of cancer and cancer therapy
  
• Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00022373 - Active, not recruiting
  Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00022594 - Active, not recruiting
  Neck Cancer; Oral Cancer; Throat Cancer
  
• Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003327 - Active, not recruiting
  Nose Cancer; Oral Cancer
  
• Expression of Hypoxia-Inducible Factor-α in Oral Precancers and Cancers
  ClinicalTrials.gov Identifier: NCT00154973 - Recruiting
  Oral Cancer
  
• RK-0202 in Preventing Oral Mucositis in Patients Who are Undergoing Radiation Therapy for Cancer of the Mouth, Throat, or Salivary Glands
  ClinicalTrials.gov Identifier: NCT00046956 - Recruiting
  lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; Oropharyngeal Cancer; radiation toxicity; ...
  
• Smoking Status and Body Image in Oral Cancer Patients
  ClinicalTrials.gov Identifier: NCT00412490 - Active, not recruiting
  Oral Cavity Cancer
  
• Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00151086 - Active, not recruiting
  Prostate Cancer
  
• Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00080873 - Active, not recruiting
  Cancer; oral complications of cancer and cancer therapy
  
• Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy
  ClinicalTrials.gov Identifier: NCT00004865 - Active, not recruiting
  Nose Cancer; Oral Cancer; Throat Cancer
  
• Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00006471 - Active, not recruiting
  Oral Cancer; Neck Cancer; Throat Cancer
  
• Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia
  ClinicalTrials.gov Identifier: NCT00056004 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Lung Cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer
  
• Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003139 - Active, not recruiting
  oral complications of cancer and cancer therapy; oropharyngeal squamous cell carcinoma; lip and oral cavity squamous cell carcinoma
  
• Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003582 - Active, not recruiting
  Nose Cancer; Oral Cancer; Throat Cancer; Quality of Life
  
• Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002476 - Active, not recruiting
  Oropharyngeal Cancer; Head and Neck Cancer; lip and oral cavity cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00004097 - Active, not recruiting
  lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Gene Therapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00009841 - Active, not recruiting
  lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002951 - Active, not recruiting
  Gastrointestinal Cancer; Neck Cancer; Oral Cancer; Throat Cancer
  
• Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00022217 - Active, not recruiting
  Nose Cancer; Oral Cancer; Throat Cancer
  
• Chemotherapy in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003103 - Active, not recruiting
  Gastrointestinal Cancer; Head and Neck Cancer; Kidney Cancer; Lung Cancer; Oral Cancer; Reproductive Cancers
  
• Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
  ClinicalTrials.gov Identifier: NCT00006994 - Active, not recruiting
  lip and oral cavity cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer; Pain; radiation toxicity
  
• Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
  ClinicalTrials.gov Identifier: NCT00002520 - Active, not recruiting
  Leukemia; Lymphoma; Head and Neck Cancer; Lung Cancer; Eye Cancer; Gastrointestinal Cancer; Oral Cancer; Reproductive Cancer
  
• SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00095628 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
  
• Radiation Therapy With or Without Epoetin alfa in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00017277 - Active, not recruiting
  Oral Cancer; Throat Cancer
  
• SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00006361 - Active, not recruiting
  lip and oral cavity cancer; Skin Cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003777 - Active, not recruiting
  Oral Cancer; Throat Cancer; Nose Cancer
  
• Adjuvant Chemoradiotherapy Using Cisplatin and Docetaxel After Complete Resection in Treating Patients With Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00084435 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
  
• Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00047008 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00083057 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer; ...
  
• Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids
  ClinicalTrials.gov Identifier: NCT00003686 - Active, not recruiting
  oral complications of cancer and cancer therapy; Quality of Life
  
• Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003251 - Active, not recruiting
  Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Fenretinide in Treating Patients With Leukoplakia of the Mouth
  ClinicalTrials.gov Identifier: NCT00004161 - Active, not recruiting
  prevention of oral cancer
  
• Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00004070 - Active, not recruiting
  lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Radiation Therapy With or Without Epoetin alfa in Anemic Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00004917 - Active, not recruiting
  Anemia; Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00049283 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer
  
• The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00173849 - Not yet recruiting
  Oral Cancer
  
• Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC
  ClinicalTrials.gov Identifier: NCT00232960 - Recruiting
  Oral Cancer; Oropharynx Cancer
  
• Wild Type p53 Adenovirus for Oral Premalignancies
  ClinicalTrials.gov Identifier: NCT00410865 - Active, not recruiting
  Mouth Cancer; Dysplasia/Carcinoma in Situ (CIS) of the Oral Cavity; Dysplasia/Carcinoma in Situ (CIS) of the Oral Pharynx
  
• Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00003182 - Active, not recruiting
  Salivary Gland Cancer; Oral Cancer; Lip Cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00006036 - Active, not recruiting
  Lung Cancer; lip and oral cavity cancer; Head and Neck Cancer; ovarian sarcoma; ovarian epithelial cancer; Oropharyngeal Cancer
  
• Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00033449 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003264 - Active, not recruiting
  Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Side Effects of High-Dose Intensity-Modulated Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00415025 - Active, not recruiting
  Head and Neck Cancer; Long-Term Effects Secondary to Cancer Therapy in Adults; Oral Complications of Cancer and Cancer Therapy; Oral Complications of Chemotherapy and Head/Neck Radiation; Radiation Toxicity
  
• Gene Therapy and Surgery Followed by Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Cancer of the Mouth or Throat
  ClinicalTrials.gov Identifier: NCT00017173 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Optical Sensor for Photodynamic Detection of Oral Pathology
  ClinicalTrials.gov Identifier: NCT00540774 - Enrolling by invitation
  Oral Diseaes; Abnormal Oral Mucosa
  
• Isotretinoin, Interferon alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00054561 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer
  ClinicalTrials.gov Identifier: NCT00021333 - Active, not recruiting
  Lung Cancer; Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Thyroid Cancer; Oropharyngeal Cancer
  
• Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00084318 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Biomarkers for Oral Cancer
  ClinicalTrials.gov Identifier: NCT00341497 - Active, not recruiting
  Oral Cancer
  
• Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00089297 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
  
• EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00004261 - Active, not recruiting
  Salivary Gland Cancer; lip and oral cavity cancer; adult soft tissue sarcoma; Head and Neck Cancer; Prostate Cancer; Cervical Cancer; ...
  
• Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004227 - Active, not recruiting
  Oral Cancer; Throat Cancer
  
• Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx
  ClinicalTrials.gov Identifier: NCT00025298 - Active, not recruiting
  stage II nasopharyngeal cancer; stage III nasopharyngeal cancer; stage IV nasopharyngeal cancer; oral complications of cancer and cancer therapy; ...
  
• Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00003898 - Active, not recruiting
  oral complications of cancer and cancer therapy; unspecified childhood solid tumor, protocol specific
  
• Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients
  ClinicalTrials.gov Identifier: NCT00549952 - Recruiting
  Oral Mucositis
  
• Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00036712 - Recruiting
  Cancer; oral complications of cancer and cancer therapy; Pain
  
• Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00003576 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer
  
• Erlotinib Prevention of Oral Cancer (EPOC)
  ClinicalTrials.gov Identifier: NCT00402779 - Recruiting
  Oral Cancer
  
• Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate
  ClinicalTrials.gov Identifier: NCT00151060 - Active, not recruiting
  Prostate Cancer
  
• Fluorescence & Reflectance Imaging to Detect Oral Neoplasia
  ClinicalTrials.gov Identifier: NCT00542373 - Recruiting
  Oral Cancer
  
• Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003193 - Active, not recruiting
  Oral Cancer; Throat Cancer
  
• Fluorescence and Reflectance Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions
  ClinicalTrials.gov Identifier: NCT00507182 - Recruiting
  Oral Cancer
  
• Evaluation of a Multispectral Vision Enhancement System for Assessment of Oral Mucosal Lesions
  ClinicalTrials.gov Identifier: NCT00502580 - Recruiting
  Oral Cancer
  
• Quality of Life and Development of Measures in Patients With Cancer of the Oral Cavity
  ClinicalTrials.gov Identifier: NCT00582413 - Recruiting
  Cancer of the Oral Cavity
  
• Celecoxib and/or EKB-569 in Preventing Oral Cancer in Patients With Oral Leukoplakia
  ClinicalTrials.gov Identifier: NCT00088842 - Not yet recruiting
  lip and oral cavity cancer; Salivary Gland Cancer; Precancerous Condition
  
• Elective vs Therapeutic Neck Dissection in the Treatment of Early Node Negative Squamous Carcinoma of the Oral Cavity
  ClinicalTrials.gov Identifier: NCT00193765 - Recruiting
  Oral Cancer
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00095875 - Recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck Cancer.
  ClinicalTrials.gov Identifier: NCT00148122 - Recruiting
  Squamous cell cancer of the oral cavity and pharynx
  
• Fruit and Vegetable Extracts in Treating Patients With Stage I, Stage II, Stage III, Stage IVA, or Stage IVB Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00064298 - Recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Docetaxel Based Chemotherapy Plus Or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)
  ClinicalTrials.gov Identifier: NCT00117572 - Recruiting
  Cancer of the Pharynx; Cancer of the Larynx; Cancer of the Nasal Cavity; Paranasal Sinus Neoplasms; Cancer of the Oral Cavity
  
• Velafermin (CG53135-05) in Preventing Oral Mucositis in Patients Receiving Chemotherapy and/or Total-Body Irradiation Followed By An Autologous Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00124592 - Recruiting
  Cancer; Drug Toxicity; oral complications of cancer and cancer therapy; radiation toxicity
  
• A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00465725 - Recruiting
  Bladder Cancer; Breast Cancer; Colorectal Cancer; Gastrointestinal Neoplasm; Head and Neck Cancer; Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer
  
• Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00002747 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity; ...
  
• Oral Health Education Program
  ClinicalTrials.gov Identifier: NCT00103493 - Active, not recruiting
  Dental Caries; Oral hygiene; Oral health; Dental health
  
• Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00042926 - Active, not recruiting
  stage I squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity
  
• An Exploratory Study on Optical Assessment of Oral Mucositis
  ClinicalTrials.gov Identifier: NCT00488332 - Recruiting
  Head and Neck Cancer; Oral Mucositis
  
• IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC
  ClinicalTrials.gov Identifier: NCT00158678 - Recruiting
  Oral Cancer; Oropharynx Cancer; Hypopharynx Cancer
  
• Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population
  ClinicalTrials.gov Identifier: NCT00359645 - Recruiting
  Pharynx Cancer; Larynx Cancer; Oral Cavity Cancer; Oesophageal Cancer
  
• Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions
  ClinicalTrials.gov Identifier: NCT00173316 - Recruiting
  Oral Cancer
  
• Accelerated Radiotherapy and Concomitant Chemo-Radiotherapy in HNSCC
  ClinicalTrials.gov Identifier: NCT00158652 - Recruiting
  Oral Cancer; Oropharynx Cancer; Hypopharynx Cancer; Larynx Cancer
  
• Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia
  ClinicalTrials.gov Identifier: NCT00052611 - Active, not recruiting
  Head and Neck Cancer
  
• Identification of Serum Markers for Tumor Hypoxia in Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00185822 - Recruiting
  Lip Cancer; Oral Cancer; Pharynx Cancer
  
• Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003313 - Active, not recruiting
  oral complications of cancer and cancer therapy; stage IIIA non-small cell lung cancer; stage II non-small cell lung cancer; Drug Toxicity; ...
  
• GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin
  ClinicalTrials.gov Identifier: NCT00044343 - Active, not recruiting
  Metastatic Colorectal Cancer
  
• The Role of Lymphangiogenesis in Head and Neck Cancer Metastasis
  ClinicalTrials.gov Identifier: NCT00173381 - Recruiting
  Oral Cancer; Laryngeal Cancer; Hypopharyngeal Cancer
  
• A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer
  ClinicalTrials.gov Identifier: NCT00393822 - Active, not recruiting
  Colon Cancer
  
• Study of Oral AP23573 to Treat Patients with Refractory or Advanced Malignancies
  ClinicalTrials.gov Identifier: NCT00112372 - Active, not recruiting
  Cancer
  
• Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00193245 - Active, not recruiting
  Lung Cancer
  
• Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00209651 - Active, not recruiting
  Colorectal Cancer
  
• Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
  ClinicalTrials.gov Identifier: NCT00002506 - Active, not recruiting
  recurrent non-small cell lung cancer; recurrent cervical cancer; recurrent squamous cell carcinoma of the lip and oral cavity; ...
  
• Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer.
  ClinicalTrials.gov Identifier: NCT00151671 - Recruiting
  Liver Cancer; Hepatocellular Carcinoma; Cirrhosis; Liver Fibrosis
  
• Oral acyclovir for neonatal HSV disease of the skin,eyes and mouth
  ClinicalTrials.gov Identifier: NCT00031447 - Active, not recruiting
  Herpes Simplex
  
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
  ClinicalTrials.gov Identifier: NCT00056407 - Active, not recruiting
  Prostate Cancer
  
• Assessment of oral acyclovir in neonates with HSV involving the CNS
  ClinicalTrials.gov Identifier: NCT00031460 - Active, not recruiting
  Herpes Simplex